Percutaneous Tract Embolization Versus Conventional Drainage Following Percutaneous Transhepatic Cholangioscopy for...

Area of Science:

• Gastroenterology
• Minimally Invasive Procedures
• Biliary Interventions

Background:

• Percutaneous transhepatic cholangioscopy (PTCS) is a key treatment for biliary diseases.
• Postoperative biliary drainage after PTCS can lead to complications and reduced quality of life.
• A novel biodegradable blockage (BB) was developed for tract embolization to replace drainage.

Purpose of the Study:

• To evaluate the safety and feasibility of biodegradable blockage (BB) for tract embolization after PTCS.
• To compare outcomes and complications of BB embolization versus standard drainage.
• To assess the impact on patient quality of life and adverse events.

Main Methods:

• Prospective study of 10 patients undergoing PTCS with BB embolization.
• Outcomes and complications were monitored for 3 months.
• A 1:1 propensity-matched control group with standard drainage was used for comparison.

Main Results:

• Successful BB placement in all patients with no procedure-related deaths.
• No significant differences in operative time, hemoglobin changes, or complication rates compared to drainage.
• The BB group experienced fewer complications (one Grade II) versus the drainage group (three complications).

Conclusions:

• Biodegradable blockage (BB) tract embolization is a safe and feasible alternative to conventional drainage post-PTCS.
• The BB approach shows promise for improving patient outcomes and quality of life.
• Larger randomized trials are necessary to validate these findings.